Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy
Clinical trial NCT00237146 · COMPLETED
Trial details
- NCT number
- NCT00237146
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-11-01
- Primary completion
- 2008-03-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.